This Is MS Multiple Sclerosis Knowledge & Support Community

Are you just reading what you see on the anonymous cafe pharma board or do you have another source of this rumor?

Full data will be released at AAN in april but here is the news release: TYSABRI-R- Two-Year Monotherapy Trial Demonstrates Significant Impact on Disability Progression and Relapse Rate in Multiple Sclerosis Thursday February 17, 2:30 am ET CAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Fe...